Quaterly Results | Tatva Chintan Pharma Chem Ltd. | R Wadiwala Securities Pvt Ltd

TATVA CHINTAN PHARMA CHEM LTD.

NSE : TATVABSE : 543321ISIN CODE : INE0GK401011Industry : ChemicalsHouse : Private
BSE1099.8048.9 (+4.65 %)
PREV CLOSE (Rs.) 1050.90
OPEN PRICE (Rs.) 1055.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2188
TODAY'S LOW / HIGH (Rs.)1055.00 1115.00
52 WK LOW / HIGH (Rs.)610 1603.6
NSE1103.8051.4 (+4.88 %)
PREV CLOSE( Rs. ) 1052.40
OPEN PRICE (Rs.) 1050.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1103.80 (45)
VOLUME 31148
TODAY'S LOW / HIGH(Rs.) 1050.00 1115.10
52 WK LOW / HIGH (Rs.)633.55 1610

Quarterly Results

Quarters
Select year
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1313.34
1235.16
1168.64
1078.64
Total Expenditure
1058.49
1013.01
995.34
989.13
PBIDT (Excl OI)
254.85
222.15
173.30
89.51
Other Income
17.34
10.08
11.55
7.22
Operating Profit
272.19
232.23
184.85
96.73
Interest
4.93
5.07
4.13
3.88
Exceptional Items
NA
NA
NA
NA
PBDT
267.26
227.16
180.72
92.85
Depreciation
90.68
90.53
89.71
72.58
Profit Before Tax
176.58
136.63
91.01
20.27
Tax
24.93
37.46
24.50
9.97
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
151.65
99.17
66.51
10.30
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
151.65
99.17
66.51
10.30
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
151.65
99.17
66.51
10.30
Equity Capital
233.92
233.92
233.92
233.92
Face Value (IN RS)
10.00
10.00
10.00
10.00
Reserves
NA
NA
NA
NA
Calculated EPS
6.48
4.24
2.84
0.44
Calculated EPS (Annualised)
25.93
16.96
11.37
1.76
No of Public Share Holdings
6544997.00
6545097.00
6545097.00
6545097.00
% of Public Share Holdings
27.98
27.98
27.98
27.98
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
19.40
17.99
14.83
8.30
PBIDTM%
20.73
18.80
15.82
8.97
PBDTM%
20.35
18.39
15.46
8.61
PBTM%
13.45
11.06
7.79
1.88
PATM%
11.55
8.03
5.69
0.95
 
Notes
Notes
Notes
Notes